Sun Yao Chen Jianlin Qiao Zhuoqing Li Yuhang Hu Jiangwei Hu Guoliang Ning Hongmei Zhang Bin Hu Liangding
10.3389/fimmu.2021.639217
Front Immunol
2021 Apr 1;12:639217.
gvhd acute myeloid leukemia hypomethylating agents immune checkpoint blockade post-transplantation relapse
CC BY
https://pubmed.ncbi.nlm.nih.gov/33868266/
Antineoplastic Combined Chemotherapy Protocols / adverse effects Graft vs Host Disease / etiology Leukemia, Myeloid, Acute / therapy
Antineoplastic Combined Chemotherapy Protocols / adverse effects Graft vs Host Disease / etiology Leukemia, Myeloid, Acute / therapy Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal, Humanized / adverse effects Azacitidine / adverse effects Combined Modality Therapy Hematopoietic Stem Cell Transplantation / adverse effects Humans Lymphoma, Follicular / drug therapy Male Middle Aged Myelodysplastic Syndromes / etiology Transplantation, Homologous Antibodies, Monoclonal, Humanized tislelizumab Azacitidine
PMC8047076
33868266
Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD
2021